about
sameAs
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s DiseaseDifferential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemiaMeningioangiomatosis in a patient with progressive focal neurological deficit-case report and review of literature.Advances in multimodal neuroimaging: hybrid MR-PET and MR-PET-EEG at 3 T and 9.4 T.Imaging of sodium in the brain: a brief review.Brain connectivity study of brain tumor patients using MR-PET data: preliminary results.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.Diagnostics of cerebral gliomas with radiolabeled amino acids.[Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.Improved nTMS- and DTI-derived CST tractography through anatomical ROI seeding on anterior pontine level compared to internal capsule.Effects of dietary tryptophan and phenylalanine-tyrosine depletion on phasic alertness in healthy adults - A pilot study.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4.QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomersThe use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.Advances in neuro-oncology imaging.O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres.Amino acid PET and MR perfusion imaging in brain tumours.Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis.Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.Functional MRI vs. navigated TMS to optimize M1 seed volume delineation for DTI tractography. A prospective study in patients with brain tumours adjacent to the corticospinal tract.Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.Simultaneous trimodal MR-PET-EEG imaging for the investigation of resting state networks in humans.Congruency of tumour volume delineated by FET PET and MRSI.Automatic derivation of an MR-PET image-based input function for quantification of 18F-FET.Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans.(18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports.Aberrant functional connectivity differentiates retrosplenial cortex from posterior cingulate cortex in prodromal Alzheimer's disease.Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.Imaging of gliomas with Cis-4-[18F]fluoro-L-proline.Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide.
P50
Q27305174-D5D352C9-EF54-4F09-B1BF-99FB3F49CC2FQ28275612-371F153C-1E7D-4BE5-8DEC-E4F1CD7FB323Q30578018-62A80199-8B6D-4535-A6FF-BECC3B64FF1DQ30585977-2F35485A-E95A-4361-BBCA-0B6FAAF4BD27Q31003866-68238660-5CAD-4756-ABB9-D400A7E0EFE3Q31054867-B51A4349-FA43-4AFD-B073-7CD64D702557Q31156299-B986504C-E463-4E85-BC62-216B0AA21102Q33487194-20354E77-4694-4D73-A222-7E42BB8CF90BQ34097192-4B061A8F-5084-4704-9FD0-A5E8485F9C86Q34571816-27B47E42-96C4-42A4-94A0-8E2041F97B27Q34863142-9E9B8B18-3BA7-44A6-8B3E-8AF8D77316F9Q35040773-17D17192-402B-4C02-BFEA-06D340E94823Q35561833-FCC427C2-5AC8-4897-A5E3-B770D738CA20Q35679377-2D010119-0ABD-4BC5-96CD-D70167E7C8BDQ35727350-F1761AB6-AB0F-4D6B-BACC-A5C30CBBD10EQ36099501-7E489D95-CEF4-46C7-9B4C-537718E0050EQ36107374-FE6B5890-6257-4392-9627-FEAD8B9C5295Q36339461-0382AA1D-2B97-40B9-A7BB-006A47F5CC60Q36456309-FCA979EE-E730-4B99-9EC5-6617BF7B072EQ36839936-70CC18CA-F22F-418B-B60A-A35C135AFC84Q37037922-ECCC8D1E-4E9D-4AC4-B8EB-D67328249D66Q38118352-DCABFE28-00E0-4845-94F4-3B8D6B9B88F9Q38605118-73B315CA-3BB9-40DE-8B1D-7B5DDD23B19AQ38620991-650A9019-B950-4C38-9926-F4DFCBB82BCEQ38691946-F4EB3A7F-8548-45BE-B7D3-2566FD5F4475Q38747089-20D1EAB8-8DA9-41FA-B83B-EF4477FB082AQ38809950-29B4926E-1E11-474E-BC44-2CDC65B08BA4Q39031636-C2EBA40F-0AD8-45A6-8519-7E6CA848252CQ39041938-E3B02B1C-8670-4E3D-B21A-10A242291ACDQ39139452-56856991-A846-4B20-99B2-CB906C5D719AQ39178360-76F2BAD4-6A2F-4FDB-A27B-BDED7F7F2CB7Q39180347-A0F20A56-9E43-4BD2-9BAE-737703C9F44DQ39180950-A962E908-13B7-464E-9BEB-BC96E6B083BBQ39181712-A2CDC990-3891-405C-B89D-9B551614920CQ39647199-0F50D966-A658-4F76-A982-8E6785D450E4Q39673304-88D291E9-6C47-4301-B712-0F344A77B187Q40232491-B9A8856E-AF38-443F-A1E9-D954066C4E21Q40333907-7F23BC2B-6758-493B-BC9C-9C27F2795F18Q40596156-AF8CD685-F0E4-4AE5-BF51-6325A90A3EA2Q40648422-70D48738-10FF-4DF0-8A04-9BC60020B2D4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karl-Josef Langen
@ast
Karl-Josef Langen
@en
Karl-Josef Langen
@es
Karl-Josef Langen
@nl
Karl-Josef Langen
@sl
type
label
Karl-Josef Langen
@ast
Karl-Josef Langen
@en
Karl-Josef Langen
@es
Karl-Josef Langen
@nl
Karl-Josef Langen
@sl
prefLabel
Karl-Josef Langen
@ast
Karl-Josef Langen
@en
Karl-Josef Langen
@es
Karl-Josef Langen
@nl
Karl-Josef Langen
@sl
P1053
H-4396-2013
P106
P1153
24383825000
P21
P31
P3829
P496
0000-0003-1101-5075